4
Changes in Ownership
Xenon Pharmaceuticals Inc. Filed Acc 0001171843-18-004796
Director acquired 12,345 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
TARNOW MICHAEL M · Director
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2018-06-21 | Exercise or conversion : show line 1 in the form | +5,144 | $3.70 | $19,033 | 60,311 | D |
| 2018-06-21 | Exercise or conversion : show line 2 in the form | +2,057 | $3.66 | $7,529 | 62,368 | D |
| 2018-06-21 | Exercise or conversion : show line 3 in the form | +5,144 | $3.07 | $15,792 | 67,512 | D |
Table II: Derivative
3 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2018-06-21 | Exercise or conversion : show line 4 in the form Stock Option (Right to Buy) | −5,144 | 0 | D |
| 2018-06-21 | Exercise or conversion : show line 5 in the form Stock Option (Right to Buy) | −2,057 | 0 | D |
| 2018-06-21 | Exercise or conversion : show line 6 in the form Stock Option (Right to Buy) | −5,144 | 0 | D |
Loading xslF345X03/formfour.xml…